FindTrial
Sign In

Exploring the relationship between immune-related blood markers and CA-125 in endometrial cancer

Significance of neutrophil: lymphocyte ratio, platelet: lymphocyte ratio, monocyte: lymphocyte ratio and their correlation with CA-125 in endometrial cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/05/087960
Enrollment
20
Registered
2025-05-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C541- Malignant neoplasm of endometrium

Interventions

Intervention1: Nil: Nil

Sponsors

Dr Shramana Mandal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All the biopsy-proven cases of endometrial cancer above 18 years of age

Exclusion criteria

Exclusion criteria: all those subjects who have received radiotherapy and chemotherapy.

Design outcomes

Primary

MeasureTime frame
1. To determine the neutrophil to lymphocyte ratio [NLR], platelet to lymphocyte ratio [PLR], monocyte to lymphocyte ratio [MLR] among the confirmed endometrial cancer patients by complete blood count [CBC] 2. To determine the values of CA -125 levels in the serum. Timepoint: 12 months—

Secondary

MeasureTime frame
1. To correlate the neutrophil to lymphocyte ratio [NLR], platelet to lymphocyte ratio [PLR], and monocyte to lymphocyte ratio [MLR] to CA125 levels. 2. To correlate the aforementioned ratios to various clinicopathological parameters like grade of tumor, depth of invasion, and clinical staging. Timepoint: 12 months—

Countries

India

Contacts

Public ContactDr Shramana mandal

Maulana Azad Medical College, New Delhi

shra_mana@hotmail.com9811686401

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026